Skip to main content

23 November 2025

Last updated: Sunday 23 November 2025

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Setting regulatory standards for advanced therapies

Saturday 10 January 2009

Interviewee/Contributor

Gabriele Schaffner-Dallmann

Organisation

NDA Regulatory Science Ltd

Organisations

Andera Partners
Neem Biotech Ltd
DCPrime BV
Novo Holdings A/S
Vivoryon Therapeutics AG
Astex Pharmaceuticals (UK)
Altheia Science Srl
Harvard Medical School
Forendo Pharma Ltd
Institute of Psychiatry, King's College Hospital

Interviewees and Contributers

John Lisman
Emma Dabbs
Alexander Natz et al
Philippe Pouletty
Rafiq Hasan
Kevin FitzGerald
David Best
Michael Salgaller, Michele Newton and Michael Pollack
Deborah O-Neil
Hugh Davies

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Werner Lanthaler appointed CEO of FairJourney Biologics

Thursday 6 November 2025

New CEO at Evaxion

Thursday 6 November 2025

Draig Therapeutics appoints President and CEO

Thursday 6 November 2025

Forbion appoints partner in growth fund

Thursday 6 November 2025

Amphista Therapeutics names executives to drive clinical development

Thursday 6 November 2025

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2025 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form